99% Savings - Buy Just @1 Rs X
Ropark 0.5 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Parkinson's Disease, Restless Legs Syndrome. Other than this, Ropark 0.5 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Ropark 0.5 Mg Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The most common side effects of Ropark 0.5 Mg Tablet are Sleepiness, Weakness, Influenza like symptoms. Apart from the aforementioned side effects, Ropark 0.5 Mg Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Ropark 0.5 Mg Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Ropark 0.5 Mg Tablet's effect during pregnancy is Moderate and Severe while nursing. Further, the section on Ropark 0.5 Mg Tablet related warnings talks about Ropark 0.5 Mg Tablet's effects on the liver, heart and kidney.
Ropark 0.5 Mg Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Psychosis as it can result in adverse effects. Some other conditions that can be affected by Ropark 0.5 Mg Tablet are listed in the contraindications section below.
Besides this, Ropark 0.5 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Ropark 0.5 Mg Tablet is not safe while driving, and is is not addictive in nature.
Ropark 0.5 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ropark 0.5 Mg Tablet safe for pregnant women?
Ropark may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Ropark again without your doctor's advice.
Is the use of Ropark 0.5 Mg Tablet safe during breastfeeding?
Ropark may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Ropark 0.5 Mg Tablet on the Kidneys?
Ropark may have mild side effects on the kidneys.
What is the effect of Ropark 0.5 Mg Tablet on the Liver?
Ropark is rarely harmful for the liver.
What is the effect of Ropark 0.5 Mg Tablet on the Heart?
Side effects of Ropark rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Ropark 0.5 Mg Tablet unless your doctor advises you to do so -
Is this Ropark 0.5 Mg Tablet habit forming or addictive?
Ropark 0.5 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Ropark 0.5 Mg Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Ropark 0.5 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Ropark 0.5 Mg Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Ropark 0.5 Mg Tablet
Taking Ropark 0.5 Mg Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Ropark 0.5 Mg Tablet
Taking Ropark 0.5 Mg Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Requip (ropinirole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1114-1116